Unknown

Dataset Information

Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.


ABSTRACT:

Purpose of review

These recommendations highlight recent experience in genetic counselling for the severe autosomal-dominant, late-onset transthyretin familial amyloid polyneuropathy (TTR-FAP) disease, and present a structured approach towards identification and monitoring of asymptomatic carriers of the mutated gene.

Recent findings

The effectiveness of current treatment options is still limited in patients with TTR-FAP beyond stage I. Diagnosis in the early stages of TTR-FAP is essential to prevent or delay the progression of disease. Existing legal and cultural issues differ among countries within Europe. Experts of the European Network for TTR-FAP (ATTReuNET) concluded that genetic counselling for diagnosed individuals and at-risk family members is mostly beneficial and

SUBMITTER: Obici L 

PROVIDER: S-EPMC4739313 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature